ImageneBio, Inc. (IMA)
4.165
+0.06
(+1.59%)
USD |
NASDAQ |
Nov 05, 16:00
ImageneBio Shareholders Equity (Quarterly) : 142.07M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 142.07M |
| March 31, 2026 | 123.33M |
| December 31, 2025 | 133.14M |
| September 30, 2025 | 139.83M |
| June 30, 2025 | 115.91M |
| March 31, 2025 | 118.25M |
| December 31, 2024 | -1.526M |
| September 30, 2024 | 134.23M |
| June 30, 2024 | 142.86M |
| March 31, 2024 | 155.35M |
| December 31, 2023 | 169.76M |
| September 30, 2023 | 187.19M |
| June 30, 2023 | 156.70M |
| March 31, 2023 | 135.02M |
| Date | Value |
|---|---|
| December 31, 2022 | 146.97M |
| September 30, 2022 | 158.79M |
| June 30, 2022 | 174.37M |
| March 31, 2022 | 192.96M |
| December 31, 2021 | 207.88M |
| September 30, 2021 | 203.26M |
| June 30, 2021 | 216.26M |
| March 31, 2021 | 227.64M |
| December 31, 2020 | -101.05M |
| September 30, 2020 | -78.50M |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | -61.46M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.387B |
| Alnylam Pharmaceuticals, Inc. | 3.604B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
| Vericel Corp. | 370.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 152.04M |
| Total Liabilities (Quarterly) | 9.971M |
| Debt to Equity Ratio | 0.0315 |
| Current Ratio | 21.47 |
| Net Debt Paydown Yield | 0.64% |